Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease
- PMID: 39729035
- PMCID: PMC11723653
- DOI: 10.18632/aging.206176
Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease
Abstract
Aging leads to nephron senescence and chronic kidney disease (CKD). In cats, indoxyl sulfate (IxS) has been previously quantified and associated with CKD, and little is known about tubular transporters. Two cohorts of cats aged 6 to 21 years were enrolled. Cohort 1 included 41 colony cats with 28 control and 13 CKD cats. Cohort 2 had 30 privately-owned cats with 10 control and 20 CKD cats. In cohort 1, serum concentrations of IxS, trimethylamine N-oxide (TMAO), p-cresol sulfate (PCS), and phenyl sulfate were higher in CKD vs. control cats (all P<0.05). This observation was independently validated in cohort 2. Renal cortical and medullar tissues were collected from a third cohort of cats euthanized for humane reasons unrelated to the study. We provided the evidence that renal tubular transporter genes, OAT1, OAT4, OATP4C1, and ABCC2, but not OAT3, were expressed in the kidneys of cats, and their expressions were downregulated in CKD (all FDR<0.1). Cats and humans share 90.9%, 77.8%, and 82.5% identities in OAT1, OATP4C1, and ABCC2 proteins, respectively. In healthy cats, circulating TMAO and IxS are significantly correlated with age. Our study reveals impaired uremic toxin secretion and tubular transporter expression in cats with CKD.
Keywords: ABCC2; OAT1; OATP4C1; indoxyl sulfate; trimethylamine N-oxide.
Conflict of interest statement
Figures





Similar articles
-
Alterations in gut-derived uremic toxins before the onset of azotemic chronic kidney disease in cats.J Vet Intern Med. 2025 Jan-Feb;39(1):e17289. doi: 10.1111/jvim.17289. J Vet Intern Med. 2025. PMID: 39739435 Free PMC article.
-
The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.J Vet Intern Med. 2019 Mar;33(2):662-669. doi: 10.1111/jvim.15389. Epub 2018 Dec 18. J Vet Intern Med. 2019. PMID: 30561098 Free PMC article.
-
GUT-DERIVED UREMIC TOXICITY IN LIONS (PANTHERA LEO) WITH CHRONIC KIDNEY DISEASE: A POTENTIAL THERAPEUTIC TARGET?J Zoo Wildl Med. 2025 Jun;56(2):258-271. doi: 10.1638/2024-0094. J Zoo Wildl Med. 2025. PMID: 40638166
-
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.Toxins (Basel). 2018 Sep 11;10(9):367. doi: 10.3390/toxins10090367. Toxins (Basel). 2018. PMID: 30208594 Free PMC article. Review.
-
Renal organic anion transporter 1: clinical relevance and the underlying mechanisms in chronic kidney disease.BMC Nephrol. 2025 Feb 24;26(1):93. doi: 10.1186/s12882-025-03974-y. BMC Nephrol. 2025. PMID: 39994543 Free PMC article. Review.
References
-
- DiBartola SP, Rutgers HC, Zack PM, Tarr MJ. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc. 1987; 190:1196–202. - PubMed
-
- Lawson JS, Liu HH, Syme HM, Purcell R, Wheeler-Jones CP, Elliott J. The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-β1. PLoS One. 2018; 13:e0202577. 10.1371/journal.pone.0202577 - DOI - PMC - PubMed
-
- Cannon M. Diagnosis and investigation of chronic kidney disease in cats. In Practice. 2016; 38:2–9.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous